{
  "@context": "aku-v2",
  "@type": "concept",
  "@id": "wsmg:health-sciences/medicine/hematology/hem-002",
  "metadata": {
    "version": "4.0.0",
    "created": "2026-01-09T01:58:35.000Z",
    "modified": "2026-01-11T00:55:00.000Z",
    "contributors": [
      "copilot-agent",
      "quality-enhancement-agent",
      "quality-agent"
    ],
    "confidence": 0.96,
    "status": "validated",
    "language": "en",
    "licenses": ["CC-BY-4.0"]
  },
  "classification": {
    "domain_path": "health-sciences/medicine/hematology",
    "subdomain": "anemias",
    "type": "definition",
    "difficulty": "intermediate",
    "importance": "high",
    "isNativeDomain": true,
    "board_yield": "HIGH"
  },
  "content": {
    "title": "Anemia of Chronic Disease",
    "summary": "Anemia of chronic disease (ACD), also termed anemia of inflammation, is a hypoproliferative anemia occurring in the setting of chronic inflammatory conditions, infections, or malignancies. It is characterized by impaired iron utilization despite adequate iron stores, mediated primarily through hepcidin-induced iron sequestration.",
    "key_points": [
      "Second most common anemia worldwide after iron deficiency",
      "Hepcidin is the central mediator blocking iron release from macrophages",
      "Normal or elevated ferritin distinguishes from iron deficiency anemia",
      "Low serum iron with low TIBC (vs high TIBC in iron deficiency)",
      "Treatment focuses on underlying disease; erythropoietin may help"
    ],
    "statement": "Anemia of chronic disease is a cytokine-mediated hypoproliferative anemia characterized by impaired iron utilization, decreased erythropoietin production, and shortened red blood cell survival, occurring secondary to chronic inflammatory, infectious, or neoplastic conditions.",
    "explanation": {
      "intuition": "Think of ACD as the body hoarding iron in storage cells during illness - an evolutionary protective mechanism to starve pathogens of iron, but which inadvertently causes anemia by limiting iron availability for red blood cell production.",
      "key_insight": "The distinguishing feature is that iron is trapped in macrophages rather than truly deficient. Hepcidin, induced by IL-6, blocks ferroportin and prevents iron export from enterocytes and macrophages.",
      "technical_details": "Pro-inflammatory cytokines (IL-6, IL-1β, TNF-α) increase hepcidin synthesis via STAT3 pathway. Hepcidin binds ferroportin causing its internalization and degradation. This reduces iron absorption and iron release from macrophages. Additionally, cytokines blunt erythropoietin response and reduce RBC survival."
    },
    "definitions_glossary": {
      "hepcidin": "A 25-amino acid peptide hormone produced by hepatocytes that is the master regulator of iron homeostasis; it reduces iron availability by degrading ferroportin",
      "ferroportin": "The only known mammalian cellular iron exporter, expressed on enterocytes, macrophages, and hepatocytes",
      "transferrin_saturation": "The ratio of serum iron to total iron-binding capacity, typically low in both ACD and iron deficiency",
      "ferritin": "The major iron storage protein; elevated or normal in ACD despite functional iron deficiency",
      "TIBC": "Total iron-binding capacity, reflects transferrin levels; low-normal in ACD but high in iron deficiency",
      "hypoproliferative_anemia": "Anemia characterized by inadequate red blood cell production relative to the degree of anemia",
      "reticuloendothelial_system": "Mononuclear phagocyte system including macrophages that store iron in ACD",
      "interleukin_6": "Pro-inflammatory cytokine that is the primary driver of hepcidin expression in ACD",
      "erythropoietin": "Hormone produced by kidneys stimulating RBC production; response blunted in ACD",
      "normochromic_normocytic": "RBCs of normal color and size, typical early presentation of ACD",
      "functional_iron_deficiency": "State where iron stores are adequate but iron availability for erythropoiesis is limited",
      "soluble_transferrin_receptor": "Marker of iron demand; elevated in iron deficiency but normal in pure ACD"
    }
  },
  "clinical_features": {
    "pathophysiology": {
      "mechanism": "Inflammatory cytokine cascade leading to hepcidin-mediated iron sequestration",
      "key_pathways": [
        "IL-6 → JAK-STAT3 → Hepcidin transcription",
        "Hepcidin → Ferroportin internalization → Iron trapping",
        "TNF-α → Blunted EPO response and reduced RBC survival",
        "IL-1β → Decreased iron absorption from enterocytes"
      ],
      "iron_kinetics": {
        "serum_iron": "Low (typically 30-60 μg/dL)",
        "TIBC": "Low to normal (typically <300 μg/dL)",
        "ferritin": "Normal to high (typically >100 ng/mL)",
        "transferrin_saturation": "Low but usually >15%"
      }
    },
    "diagnostic_criteria": {
      "essential": [
        "Presence of chronic inflammatory, infectious, or malignant condition",
        "Mild to moderate normocytic normochromic anemia",
        "Low serum iron with low-normal TIBC"
      ],
      "supportive": [
        "Elevated ferritin (>100 ng/mL)",
        "Normal or low reticulocyte count",
        "Elevated inflammatory markers (CRP, ESR)"
      ],
      "distinguishing_from_IDA": {
        "ferritin": ">100 ng/mL in ACD vs <30 ng/mL in IDA",
        "TIBC": "Low-normal in ACD vs elevated in IDA",
        "sTfR_ferritin_ratio": "<1 in ACD vs >2 in IDA"
      }
    },
    "differential_diagnosis": [
      "Iron deficiency anemia (may coexist)",
      "Anemia of chronic kidney disease",
      "Sideroblastic anemia",
      "Myelodysplastic syndrome",
      "Thalassemia minor"
    ],
    "treatment_options": {
      "primary": "Treat underlying inflammatory condition",
      "adjunctive": [
        "Erythropoiesis-stimulating agents (ESAs) if Hgb <10 g/dL",
        "IV iron if concurrent true iron deficiency (ferritin <100 and TSAT <20%)",
        "Transfusion for severe symptomatic anemia"
      ],
      "emerging": [
        "Anti-hepcidin antibodies",
        "Ferroportin agonists",
        "HIF-PHD inhibitors (roxadustat)"
      ]
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Anemia of Chronic Disease"
    },
    "altLabel": [
      {"@language": "en", "@value": "Anemia of inflammation"},
      {"@language": "en", "@value": "ACD"},
      {"@language": "en", "@value": "Anemia of chronic inflammation"},
      {"@language": "en", "@value": "Functional iron deficiency anemia"}
    ],
    "definition": {
      "@language": "en",
      "@value": "A hypoproliferative anemia occurring in settings of chronic inflammation, infection, or malignancy, characterized by impaired iron utilization due to hepcidin-mediated iron sequestration despite adequate iron stores"
    },
    "notation": "hem-002",
    "scopeNote": {
      "@language": "en",
      "@value": "Distinct from iron deficiency anemia; iron stores are adequate but functionally unavailable"
    }
  },
  "relationships": {
    "skos:broader": [
      {
        "@id": "wsmg:health-sciences/medicine/hematology/anemias",
        "skos:prefLabel": "Anemias"
      },
      {
        "@id": "wsmg:health-sciences/medicine/hematology/hypoproliferative-anemias",
        "skos:prefLabel": "Hypoproliferative Anemias"
      }
    ],
    "skos:narrower": [],
    "skos:related": [
      {
        "@id": "wsmg:health-sciences/medicine/hematology/hem-001",
        "skos:prefLabel": "Iron Deficiency Anemia"
      },
      {
        "@id": "wsmg:health-sciences/medicine/nephrology/anemia-of-ckd",
        "skos:prefLabel": "Anemia of Chronic Kidney Disease"
      }
    ],
    "enables": [
      {
        "@id": "wsmg:health-sciences/medicine/rheumatology/ra-complications",
        "reason": "Common complication in rheumatoid arthritis"
      }
    ],
    "owl:sameAs": [
      "http://dbpedia.org/resource/Anemia_of_chronic_disease"
    ]
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codingSystem": "SNOMED-CT",
      "codeValue": "234349001",
      "uri": "http://snomed.info/id/234349001",
      "description": "Anemia of chronic disorder"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "ICD-10-CM",
      "codeValue": "D63.8",
      "uri": "http://hl7.org/fhir/sid/icd-10-cm/D63.8",
      "description": "Anemia in other chronic diseases classified elsewhere"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "MeSH",
      "codeValue": "D000740",
      "uri": "http://id.nlm.nih.gov/mesh/D000740",
      "description": "Anemia"
    }
  ],
  "pedagogical": {
    "learning_objectives": [
      "Explain the pathophysiology of anemia of chronic disease including hepcidin's role",
      "Differentiate ACD from iron deficiency anemia using iron studies",
      "Identify clinical conditions commonly associated with ACD",
      "Describe the iron kinetics pattern characteristic of ACD",
      "Outline treatment strategies for ACD"
    ],
    "clinical_pearls": [
      "Ferritin >100 ng/mL with low serum iron strongly suggests ACD over IDA",
      "The sTfR/log ferritin index <1 favors ACD; >2 favors IDA",
      "Many patients have combined ACD and iron deficiency - treat both",
      "ESAs may be effective but monitor for thrombotic risks",
      "Treating the underlying condition is the most effective therapy"
    ],
    "board_yield": "HIGH",
    "estimated_time": "20min",
    "target_audience": [
      "medical_students",
      "internal_medicine_residents",
      "hematology_fellows"
    ],
    "common_misconceptions": [
      "ACD always causes mild anemia - can be moderate to severe in chronic conditions",
      "Iron supplementation helps ACD - usually ineffective as iron is already adequate",
      "Low ferritin rules out ACD - concurrent iron deficiency can lower ferritin"
    ]
  },
  "prerequisites": [
    {
      "@id": "wsmg:health-sciences/medicine/hematology/iron-metabolism",
      "skos:prefLabel": "Iron Metabolism"
    },
    {
      "@id": "wsmg:health-sciences/medicine/hematology/hem-001",
      "skos:prefLabel": "Iron Deficiency Anemia"
    }
  ],
  "related_concepts": [
    "iron deficiency anemia",
    "hepcidin regulation",
    "inflammatory cytokines",
    "erythropoietin resistance"
  ],
  "evidence": {
    "citations": [
      {
        "authors": "Weiss G, Ganz T, Goodnough LT",
        "title": "Anemia of inflammation",
        "journal": "Blood",
        "year": 2019,
        "volume": "133",
        "pages": "40-50",
        "doi": "10.1182/blood-2018-06-856500"
      },
      {
        "authors": "Nemeth E, Ganz T",
        "title": "Anemia of Inflammation",
        "journal": "Hematol Oncol Clin North Am",
        "year": 2014,
        "volume": "28",
        "pages": "671-681",
        "doi": "10.1016/j.hoc.2014.04.005"
      }
    ],
    "confidence_rationale": "Well-established pathophysiology with extensive clinical and laboratory evidence"
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-11T00:55:00.000Z",
    "sources": [
      {
        "source": "Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133(1):40-50.",
        "type": "review_article",
        "year": 2019,
        "relevance": "Comprehensive pathophysiology review"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill, 2022.",
        "type": "textbook",
        "year": 2022,
        "isbn": "978-1264268504",
        "relevance": "Standard medical reference"
      },
      {
        "source": "UpToDate. Anemia of chronic disease/anemia of inflammation. 2024.",
        "type": "clinical_reference",
        "year": 2024,
        "relevance": "Current clinical guidance"
      }
    ]
  },
  "quality_assessment": {
    "content_quality_score": 0.92,
    "completeness": 0.94,
    "accuracy": 0.95,
    "clarity": 0.90,
    "clinical_relevance": 0.95,
    "last_assessed": "2026-01-11T00:55:00.000Z"
  },
  "owl:sameAs": "http://dbpedia.org/resource/Anemia_of_chronic_disease",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q4752892"
}